These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8561608)

  • 1. Insights into thromboembolism and bleeding.
    Addonizio VP
    Ann Thorac Surg; 1996 Jan; 61(1):374-5; discussion 378-9. PubMed ID: 8561608
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface.
    Achneck HE; Sileshi B; Parikh A; Milano CA; Welsby IJ; Lawson JH
    Circulation; 2010 Nov; 122(20):2068-77. PubMed ID: 21098468
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelialization and late stent thrombosis in diabetics.
    Kaneda H
    J Am Coll Cardiol; 2008 Dec; 52(25):2213; author reply 2213. PubMed ID: 19095143
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of microvascular thromboembolism in vivo.
    Egbrink MG; Van Gestel MA; Broeders MA; Tangelder GJ; Heemskerk JM; Reneman RS; Slaaf DW
    Microcirculation; 2005; 12(3):287-300. PubMed ID: 15814437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microvascular endothelial dysfunction as a factor of metastasis].
    Petrishchev NN; Dubina MV
    Vopr Onkol; 1999; 45(5):484-92. PubMed ID: 10629703
    [No Abstract]   [Full Text] [Related]  

  • 6. Clotting and Bleeding in Oncology Patients: Clinical Scenarios and Challenges.
    Komatsubara KM; Diuguid DL
    Oncology (Williston Park); 2016 Oct; 30(10):936-40. PubMed ID: 27753062
    [No Abstract]   [Full Text] [Related]  

  • 7. One of possible mechanisms on no-reflow in post-percutaneous coronary intervention: coronary shock due to micro-coronary stunning.
    Li G; Liu T
    Med Hypotheses; 2005; 65(4):814. PubMed ID: 15996832
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology of thromboembolism and its modulation by low-molecular-weight heparins.
    Breddin HK
    Semin Thromb Hemost; 1996; 22 Suppl 1():25-7. PubMed ID: 8807725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood constitution: platelet aggregation, bleeding, and involvement of leukocytes.
    Goto S
    Rev Neurol Dis; 2008; 5 Suppl 1():S22-7. PubMed ID: 18645568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of action of old and new anticoagulants].
    Stämpfli SF; Asmis LM; Tanner FC
    Herz; 2008 Feb; 33(1):4-12. PubMed ID: 18273572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early growth response factor-1.
    Elefteriades JA; Collins MJ
    J Am Coll Cardiol; 2009 Mar; 53(9):800-1. PubMed ID: 19245973
    [No Abstract]   [Full Text] [Related]  

  • 12. Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
    van Heeckeren WJ; Sanborn SL; Narayan A; Cooney MM; McCrae KR; Schmaier AH; Remick SC
    Curr Opin Hematol; 2007 Sep; 14(5):468-80. PubMed ID: 17934353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian variation within hemostasis: an underrecognized link between biology and disease?
    Montagnana M; Salvagno GL; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):23-33. PubMed ID: 19308890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
    Yu A; Egberg N; Jacobson SH
    Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of coding for possible warfarin complications in hospital discharge abstracts.
    Arnason T; Wells PS; van Walraven C; Forster AJ
    Thromb Res; 2006; 118(2):253-62. PubMed ID: 16081144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypercortisolism and hemostasis].
    Swiatkowska-Stodulska R; Babińska A; Sworczak K
    Pol Merkur Lekarski; 2009 Feb; 26(152):142-4. PubMed ID: 19388521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity of antithrombin III in the blood of patients with bladder cancer].
    Zietek Z; Iwan-Zietek I; Kotschy M; Wiśniewska E; Tyloch F
    Pol Merkur Lekarski; 1997 Apr; 2(10):268-9. PubMed ID: 9377663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE).
    López-Jiménez L; Montero M; González-Fajardo JA; Arcelus JI; Suárez C; Lobo JL; Monreal M;
    Haematologica; 2006 Aug; 91(8):1046-51. PubMed ID: 16885044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early growth response factor-1 is associated with intraluminal thrombus formation in human abdominal aortic aneurysm.
    Shin IS; Kim JM; Kim KL; Jang SY; Jeon ES; Choi SH; Kim DK; Suh W; Kim YW
    J Am Coll Cardiol; 2009 Mar; 53(9):792-9. PubMed ID: 19245972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.